Individual recombinant repeats of MUC16 display variable binding to CA125 antibodies

Abstract

BACKGROUND: Despite its importance in the clinical management of ovarian cancer, the CA125 biomarker, located on the mucin protein MUC16, is still not completely understood. Questions remain about MUC16 function and structure, specifically the identity and location of the CA125 epitopes. OBJECTIVE: The goal of this study was to characterize the interaction of individual recombinant repeats from the tandem repeat domain of MUC16 with antibodies used in the clinical CA125 II test. METHODS: Using E. coli expression, we isolated nine repeats from the putative antigenic domain of CA125. Amino acid composition of recombinant repeats was confirmed by high-resolution mass spectrometry. We characterized the binding of four antibodies, OC125, M11, OC125-like, and M11-like, to nine recombinant repeats using Western blotting, indirect enzyme-linked immunosorbent assay (ELISA), and localized surface plasmon resonance (SPR) spectroscopy. RESULTS: Each recombinant repeat was recognized by a different combination of CA125 antibodies. OC125 and OC125-like antibodies did not bind the same set of recombinant repeats, nor did M11 and M11-like antibodies. CONCLUSIONS: Characterization of the interactions between MUC16 recombinant repeats and CA125 antibodies will contribute to ongoing efforts to identify the CA125 epitopes and improve our understanding of this important biomarker.